Toby Cosgrove, Cleveland Clinic CEO, discusses the impact of the Affordable Care Act on patients, including what they will pay and the strain on the nation's Medicare and Medicaid systems. And Aetna CEO Mark Bertolini, weighs in.» Read More
CNBC's Phil Lebeau talks with Alan Mulally, Ford Motor Company president & CEO, about why his company is focusing attention on its Lincoln luxury brand, which was down four percent last year.
CNBC's Phil LeBeau talks with Ludwig Willisch, BMW North America president & CEO, about the automaker's efforts to attract the high-end consumer with luxury features in its newest series of cars.
AthenaHealth co-founder, chairman and CEO Jonathan Bush discusses whether the Affordable Care Act could give his company a boost, and its decision to acquire mobile clinical info provider Epocrates.
Dr. Bruce Bedrick, CEO of Medbox, offers insight on his business amid the trend of making marijuana legal.
BATS, the third largest stock exchange in the U.S., overcharged members $420,000 from 2008 - 2012 on certain orders. CNBC's Bob Pisani explains.
Michael Johnson, Herbalife CEO, discusses his company's business model and explains how distributors receive compensation, with CNBC's Kate Kelly.
Eric Migicovsky, Pebble CEO & co-founder, discusses the launch of its much-buzzed about wearable "data plan."
Mario Gabelli, GAMCO Investors chairman, CEO & CIO, reveals his top stock plays for 2013, and weighs in on the outlook on the U.S. economy and "payroll shock" hitting workers' paychecks.
Charles River Laboratories CEO James Foster discusses competition in the drug market, drug patents and where his business is headed in 2013.
Acorda Therapeutics CEO Dr. Ron Cohen discusses the phase 2 studies happening on its mobility improvement drug Ampyra, and what's next for the company.
CNBC's Mary Thompson has been following AIG's board meeting and offers details. Meanwhile Robert Benmosche, AIG CEO, explains why he decided not to join Hank Greenberg's lawsuit.
Rob Sands, president & CEO of Constellation Brands, sizes up wine and beer sales.
Shares of AOL are up more than eighty percent year-over-year. Tim Armstrong, chairman & CEO of AOL, discusses where he is finding patches of profitability, with CNBC's Julia Boorstin.
CNBC's Phil LeBeau talks with Daniel Akerson, General Motors chairman & CEO, about when the automaker expects to become profitable, and discuss the company's new "Find New Roads" branding slogan.
"I think this is the year asset allocations switch back over to stocks," explains Cliff Corso, Cutwater Asset Management CEO, discussing what's driving investors from bonds to equities now.
Biogen Idec CEO George Scangos speaks to Mad Money host about what the company is doing now to treat multiple sclerosis.
Alcoa CEO Klaus Kleinfeld discusses quarterly earnings, and his expectations for markets and business in 2013.
CNBC's Maria Bartiromo reports Alcoa's Q4 earnings.
CNBC's Jon Fortt speaks to Qualcomm CEO Paul Jacobs about the new line of smartphone chips for 2013, and the smartphone war.
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.